Lab-Developed Intestinal Organoids Form Mature Human Tissue in Mice

(Eurekalert) – Researchers have successfully transplanted “organoids” of functioning human intestinal tissue grown from pluripotent stem cells in a lab dish into mice – creating an unprecedented model for studying diseases of the intestine. Reporting their results Oct. 19 online … Read More

New Insight That ‘Mega’ Cells Control the Growth of Blood-Producing Cells

(Medical Xpress) – While megakaryocytes are best known for producing platelets that heal wounds, these “mega” cells found in bone marrow also play a critical role in regulating stem cells according to new research from the Stowers Institute for Medical … Read More

HSCI Lab Explores More Efficient Ways to Generate iPS Cells

(Harvard Stem Cell Institute) – Harvard Stem Cell Institute scientists at Massachusetts General Hospital have found that adding two small molecules to the four classic “Yamanaka factors” generates the fastest mouse induced pluripotent stem (iPS) cells ever reported. This simple tweak … Read More

Scietists Identify “Naive-like” Human Stem Cell

( – The human embryonic stem cells (ESCs) that scientists currently study in the lab are able to develop into several different types of cell but are already pre-determined to some extent. Published in the top scientific journal Nature, researchers … Read More

Team Discovers Stem Cells in the Esophagus

(Medical Xpress) – Despite previous indications to the contrary, the esophagus does have its own pool of stem cells, said researchers from the University of Pittsburgh School of Medicine in an animal study published online today in Cell Reports. The … Read More

Stem Cells’ Rapid Response Due to Short-Lived RNA Messages

(Standford Medicine) – Many stem cells live a life of monotony, biding their time until they’re needed to repair tissue damage or propel the growth of a developing embryo. But when the time is right, they must spring into action … Read More

T-Cell Therapy Puts Leukemia Patients in Extended Remission

(New York Times) – An experimental therapy has brought prolonged remissions to a high proportion of patients who were facing death from advanced leukemia after standard treatments had failed, researchers are reporting. The therapy involves genetically programming cells from the … Read More

RSS from